Product - Exo-PTEN
Initial indications of the study show the potential for an off the shelf (not personalized) product, which could be developed to treat shortly after an accident with the aim of improving chances of recovery and, reducing the damage from SCI.
The aim will be to have the ability to treatment any SCI, including new injuries and long term existing injuries. Activating any level of recovery, either partial or otherwise would make a significant change for the patient, improving their quality of life.
The table below summarize the advantages of NurExone technology.